Greenwich LifeSciences
- | Biotech or pharma, therapeutic R&D
Conducting Phase III trial for HER2/neu Breast Cancer patients to prevent the recurrence of cancer following surgery. Phase IIb trial with median 5 years follow-up showed substantial reduction in recurrence rates and no SAEs related to treatment.
Address
StaffordTX
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}